Selenium-based nanoparticle (SeNP) treatment for preventive and therapeutic use against bacteria. Our product, SYN-BAC, uses bacteria to produce corresponding therapeutic SeNPs with the aim of using them as antimicrobials towards the same bacteria that produce them. This approach is analogous to a Nanometric Trojan Horse to treating bacterial infections.
Primary Application Area: Biotech, Pharma, Health
Technology Development Status: Concept
Technology Readiness Level: TRL 3
Organization Type: Early-stage Startup (Seed)
GOVT/EXTERNAL FUNDING SOURCES